GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Role of Fibroblasts, Myeloid Cells and Matrix in PDAC

$586,932
Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U01 · FY2013 · CA

Ras-mediated signals in human epithelial cell transformation and metastasis

$586,874
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Radiomic spatial maps for identifying viable tumor extent on multi-parametric MRI for Glioblastoma

$586,765
Pallavi Tiwari · University Of Wisconsin-Madison · R01 · FY2025 · CA

Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma

$586,680
Sandi Alexander Kwee · Queen'S Medical Center · R01 · FY2023 · CA

Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas

$586,565
Richard J Price · University Of Virginia · R01 · FY2022 · EB

Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer

$586,431
Jose M Silva · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

NOVEL THERAPRUTIC TARGETS TO INHIBIT TUMOR MICROENVIRONMENT-INDUCED CASTRATION-RESISTANT PROSTATE CEN=CER

$586,403
Baylor College Of Medicine · · FY2013 · Department of the Army

The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

$586,386
Kit S Lam · University Of California At Davis · U01 · FY2018 · CA

The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

$586,386
Kit S Lam · University Of California At Davis · U01 · FY2017 · CA

The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

$586,386
Kit S Lam · University Of California At Davis · U01 · FY2016 · CA

Engineering immunotherapeutic probiotics to mitigate irAE

$586,329
Tal Danino · Columbia Univ New York Morningside · U01 · FY2020 · CA

Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy

$586,195
Mathewos Tessema · Lovelace Biomedical & Environmental Research Institute · R01 · FY2019 · CA

Fully Quantitative Low-Dose, Motion-Resolved Dynamic Contrast-Enhanced MRI in Pancreatic Adenocarcinoma

$586,150
Anthony G Christodoulou · Cedars-Sinai Medical Center · R01 · FY2023 · EB

Fully Quantitative Low-Dose, Motion-Resolved Dynamic Contrast-Enhanced MRI in Pancreatic Adenocarcinoma

$586,150
Anthony G Christodoulou · Cedars-Sinai Medical Center · R01 · FY2022 · EB

Enhancing the efficacy of radiation by spatially restricting anti-TGFb treatment to the tumor

$585,976
Kristina H Young · Providence Health & Services - Oregon · R01 · FY2025 · CA

Single-cell congruence evaluation and selection of cancer models towards precision medicine

$585,931
George C. Tseng · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma

$585,923
Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2025 · CA

PET-EPRI

$585,915
Raymond Robert Raylman · West Virginia University · R01 · FY2020 · EB

Project 1:The Carolina Breast Cancer Study

$585,858
Melissa A. Troester · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA

Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma

$585,801
Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

Targeting MTOR signaling in pancreatic cancer

$585,758
Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA

Immunobiology and immunotherapy of pancreatic cancer

$585,722
Robert H Vonderheide · University Of Pennsylvania · R01 · FY2013 · CA

Project 1:The Carolina Breast Cancer Study

$585,719
Melissa A. Troester · Univ Of North Carolina Chapel Hill · P50 · FY2021 · CA

Systemic RNA Delivery to Tumors

$585,626
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2021 · CA

Reprogramming the Tumor Immune Microenvironment with Chemokines to Potentiate Immune Oncology Treatments in Oral Cancer

$585,606
J. Silvio Gutkind · University Of California, San Diego · R01 · FY2025 · DE